When our nation’s heroes return home, they often face a quiet suffering — something I have seen happen so often in my peers. As a combat veteran and an advocate for those who have worn the uniform, I know that so many of us face these challenges long after we return home. Post-traumatic stress (PTS) is a battlefield of its own — invisible, relentless, and too often fought alone.
Over the years, I’ve dedicated my life to improving the lives of our veterans, whether serving as a Veterans Fellow and Lead Policy Advisor on Military and Veterans Affairs to Sen. Chuck Grassley, leading within the Iowa Veterans of Foreign Wars (VFW), or conducting academic research focused on veterans’ issues. One thing has become undeniably clear: it’s time to reschedule cannabis as a Schedule III substance under federal law, a change that is backed by President Donald Trump, which would open the door for unlocking its therapeutic potential for veterans suffering from PTS and other chronic illnesses.
Currently, cannabis remains a Schedule I substance — the same category as heroin — defined as having “no accepted medical use” and a “high potential for abuse.” This is not only scientifically outdated, but also morally indefensible. Veterans are not asking for a miracle cure. We are asking for options. We are asking for the freedom to explore alternative treatments when conventional therapies — prescription medications, talk therapy, or exposure therapy — fall short. For many veterans, they do. And for some, cannabis has helped where nothing else has.
Hellbound and Down 